Clinical Trials Directory

Trials / Conditions / Retinal Neovascularization

Retinal Neovascularization

14 registered clinical trials studyying Retinal Neovascularization — 1 currently recruiting.

StatusTrialSponsorPhase
UnknownHome OCT Guided Management Study of Subjects Diagnosed With Neovascular-AMD
NCT05650047
Notal Vision Inc.—
UnknownHigh Resolution Optical Coherence Tomography
NCT05130385
Insel Gruppe AG, University Hospital Bern—
RecruitingEfficacy and Safety of Intravitreal Injection of Bevacizumab with and Without Oral Curcumin
NCT06595355
Isfahan University of Medical SciencesPhase 2 / Phase 3
CompletedDaily Testing at Home by NV-AMD Subjects With Notal Home OCT.
NCT04650672
Notal Vision Inc.—
CompletedStudy of the Modification of the Retinal Nerve Fiber Layer in Patients Treated With Intravitreous Injection of
NCT02876198
Fondation Ophtalmologique Adolphe de Rothschild—
UnknownZiv-aflibercept in Ocular Disease Requiring Anti-VEGF Injection
NCT02486484
Rafic Hariri University HospitalPhase 2
UnknownLongterm Efficiency and Safety of Intravitreal Injections With Bevacizumab in Patients With Neovascularisation
NCT03211741
University Hospital, GhentPhase 4
CompletedSqualamine for the Treatment in Proliferative Diabetic Retinopathy
NCT01769183
Elman Retina GroupPhase 2
CompletedSafety and Efficacy Study of rAAV.sFlt-1 in Patients With Exudative Age-Related Macular Degeneration
NCT01494805
Lions Eye Institute, Perth, Western AustraliaPhase 1 / Phase 2
TerminatedSelective Retinal Pigment Epithelium Laser Therapy for Macular Disease of the Retina
NCT02088151
Insel Gruppe AG, University Hospital BernN/A
CompletedSafety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AM
NCT01024998
Genzyme, a Sanofi CompanyPhase 1
CompletedPanretinal Photocoagulation (PRP) Plus Ranibizumab for Proliferative Diabetic Retinopathy
NCT01102946
University of Sao PauloPhase 2
CompletedIntravitreal Avastin in Proliferative Retinopathies
NCT00564148
Ophthalmological Association EdelweissPhase 2
CompletedKrypton-Argon Regression of Neovascularization Study (KARNS)
NCT00000153
National Eye Institute (NEI)Phase 3